Experts are rapidly focused on retatrutide compounds , a novel dual agonist targeting both GLP-1 and GIP receptors. This unique mechanism suggests to present substantial benefit for weight loss and related health issues . Early clinical trials have revealed encouraging results, suggesting a potential change in how we address excess weight and a… Read More